Edwards Lifesciences (EW) Tops Q4 EPS by 11c, FY15 EPS Guidance Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Edwards Lifesciences (EW) Estimates Raised at Jefferies Following 'Stellar' Q4
February 4, 2015 8:43 AM ESTJefferies analyst Raj Denhoy reiterated a Buy rating and $155 price target on Edwards Lifesciences (NYSE: EW) while raising estimates following strong q4 results.
Denhoy commented, "EW posted a stellar 4Q, highlighted by (1) robust TAVR performance across geographies, particularly EU, despite increasing competitionand the... More
